Antibody Drug Conjugate (ADC) for TNBC

Triple-negative breast cancer (TNBC) accounts for approximately 10 to 15 percent of all breast cancers. In triple-negative breast cancer (TNBC), the unhealthy cells typically don’t have estrogen or progesterone receptors (ER or PR) and they create very little or none of the human epidermal growth factor receptor 2 (HER2) protein. Antibody-drug conjugate (ADC): An antibody-drug conjugate […]

Triple-Negative Breast Cancer And their Treatment

Breast cancer is a type of cancer in which cells in the breast grow out of control. There are different kinds of breast cancer. The kind of breast cancer depends on which cells in the breast turn into cancer. Normal breast cells have receptors that respond to hormones such as estrogen and progesterone, which allows […]